We offer a variety of custom DNA oligos tailored to meet your needs!
At Ajinomoto Bio-Pharma Services Gene Design, we provide high-quality oligonucleotide DNA that can be used with confidence, thanks to our consistent quality control from order to delivery. 【Synthesis Scale / Guaranteed Amount】 ■ 0.2 μmol scale synthesis ■ 1 μmol scale synthesis ■ mg, g, kg guarantee 【Quality Grade】 ■ Simple column purification ■ HPLC purification ■ in vivo ■ GMP 【Features】 ■ High-quality oligo DNA provided through technology cultivated over many years of experience ■ Extensive modification services (PS modification, 2'-OMe, 2'-MOE, LNA, etc.) ■ Numerous achievements in fluorescent modifications and functional compound modifications (PEG, peptides, etc.) *For more details, please refer to the external link page or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the external link page or feel free to contact us.
Price range
P2
Delivery Time
P4
Applications/Examples of results
For more details, please refer to the external link page or feel free to contact us.
Company information
Ajinomoto Bio-Pharma Services and GeneDesign, Inc. are engaged in the production of oligonucleotides, incorporating the latest technologies and patent licenses from various research institutions. We supply distinctive nucleic acid materials, including the introduction of artificially modified nucleic acids and the addition of functional molecules, contributing to the development of new technologies in the gene-related fields (such as drug development, diagnostic technology development, and bio-research technology development). Currently, the demand for various synthetic nucleic acids is expanding from cell culture levels to animal testing and further to clinical trials. Our company has established a system capable of supplying everything from research reagents to investigational drugs at all scales, and we are advancing research and development daily as a company that can significantly contribute to the creation of nucleic acid pharmaceuticals and the practical application of diagnostic systems. For the future of medicine, we aim to be a company that contributes to the welfare and health of people through the development of nucleic acid manufacturing technologies, actively working on the development of next-generation nucleic acid drugs and diagnostic materials.
![Oligo DNA derived from microbial genomes [Shinshu University Agriculture]](https://image.mono.ipros.com/public/product/image/a52/2000829503/IPROS3898321288668949087.png?w=280&h=280)
